Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
366
-
Total 13F shares, excl. options
-
43.7M
-
Shares change
-
-2.64M
-
Total reported value, excl. options
-
$5.13B
-
Value change
-
-$335M
-
Put/Call ratio
-
0.42
-
Number of buys
-
157
-
Number of sells
-
-173
-
Price
-
$117.19
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2017
426 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q3 2017.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 366 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.7M shares
of 44.8M outstanding shares and own 97.48% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.8M shares), FMR LLC (4.21M shares), VANGUARD GROUP INC (3.54M shares), AQR CAPITAL MANAGEMENT LLC (2.18M shares), STATE STREET CORP (2.09M shares), Palo Alto Investors, LLC (1.76M shares), RENAISSANCE TECHNOLOGIES LLC (1.27M shares), GOLDMAN SACHS GROUP INC (1.13M shares), ACADIAN ASSET MANAGEMENT LLC (1.09M shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (1.05M shares).
This table shows the top 366 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.